Alpa Laboratories has transferred its oral solid dosage formulations manufacturing Unit-II situated at sector III, Pithampur, Dhar in state of Madhya Pradesh, to Ipca Laboratories. This transfer has taken place pursuant to both the BTA & the NCA been executed on October 01, 2014. The sale of the facility will enable the company in focusing on the growth of its well established business of Unit-I.
Earlier, the company subsequent to the shareholders approval dated April 04, 2014, has sold its Unit-II as a going concern on a slump sale basis to Ipca Laboratories. The company has received a consideration of Rs 64 crore towards the Business Transfer Agreement (BTA) as a going concern on a slump sale basis and a fee of Rs 10 lakh excluding taxes towards the Non Compete Agreement (NCA) from the Ipca.
Alpa Laboratories manufactures a spectrum of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products. These products are manufactured in various dosage forms such as injectables (vials/ampoules both liquid and dry), tablets, capsules, eye/ear drops, ointment and creams.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: